Cogent Biosciences, Inc. COGT
- bezuclastinib — Non-Advanced Systemic Mastocytosis NDA Submitted
- bezuclastinib — Gastrointestinal Stromal Tumor NDA Submitted
- bezuclastinib — Advanced Systemic Mastocytosis NDA Submitted
KIT D816V (1 companies · 3 programs)
Companies with an active program directed at KIT D816V.